ibudilast and Rheumatoid Arthritis studies

ibudilast and Rheumatoid Arthritis

ibudilast has been researched along with Rheumatoid Arthritis in 1 studies

Research Excerpts

Excerpt	Relevance	Reference
"Ibudilast is a well-tolerated, orally available phosphodiesterase 4 (PDE4) inhibitor used to treat asthma and stroke."	5.51	Ibudilast Inhibits Chemokine Expression in Rheumatoid Arthritis Synovial Fibroblasts and Exhibits Immunomodulatory Activity in Experimental Arthritis. ( Clanchy, FIL; Williams, RO, 2019)
"Ibudilast is a well-tolerated, orally available phosphodiesterase 4 (PDE4) inhibitor used to treat asthma and stroke."	1.51	Ibudilast Inhibits Chemokine Expression in Rheumatoid Arthritis Synovial Fibroblasts and Exhibits Immunomodulatory Activity in Experimental Arthritis. ( Clanchy, FIL; Williams, RO, 2019)

Research

Studies (1)

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

1 (100.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Clanchy, FIL	1
Williams, RO	1

Studies

Clanchy, FIL

Williams, RO

Other Studies

1 other study available for ibudilast and Rheumatoid Arthritis

Article	Year
Ibudilast Inhibits Chemokine Expression in Rheumatoid Arthritis Synovial Fibroblasts and Exhibits Immunomodulatory Activity in Experimental Arthritis. Arthritis & rheumatology (Hoboken, N.J.), 2019, Volume: 71, Issue:5 Topics: Adoptive Transfer; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Chemokine CCL5; Chemokin	2019

Article

Year

Arthritis & rheumatology (Hoboken, N.J.), 2019, Volume: 71, Issue:5

Topics: Adoptive Transfer; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Chemokine CCL5; Chemokin

2019